Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Tetraphase Pharmaceuticals Antibiotic Fails Against J&J Drug In Trial; Stock Plunges 79% After-Hours
Tetraphase Pharmaceuticals Antibiotic Fails Against J&J Drug In Trial; Stock Plunges 79% After-Hours
Tetraphase Pharmaceuticals Antibiotic Fails Against J&J Drug In Trial; Stock Plunges 79% After-Hours
Submitted by
admin
on September 9, 2015 - 8:07am
Source:
Bidness, ETC
News Tags:
Tetraphase Pharmaceuticals
JNJ
antibiotics
Eravacycline
superbugs
Headline:
Tetraphase Pharmaceuticals Antibiotic Fails Against J&J Drug In Trial; Stock Plunges 79% After-Hours
Do Not Allow Advertisers to Use My Personal information
